世界の臨床栄養市場予測2019-2028

◆英語タイトル:GLOBAL CLINICAL NUTRITION MARKET FORECAST 2019-2028
◆商品コード:INK20AG035
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年8月
◆ページ数:174
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、臨床栄養の世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、投与経路別(経口、経腸、非経口)分析、用途別分析、エンドユーザー別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・臨床栄養の世界市場規模:投与経路別(経口、経腸、非経口)
・臨床栄養の世界市場規模:用途別
・臨床栄養の世界市場規模:エンドユーザー別
・臨床栄養の世界市場規模:地域別
・企業情報
【レポートの概要】

KEY FINDINGS
The global clinical nutrition market is projected to register a CAGR of 5.11% during the forecast period, 2019-2028. The factors contributing to the growth of the market are the growing prevalence of lifestyle-associated diseases, increasing geriatric population, rising demand in developing countries, and a high occurrence of malnutrition among patients.

MARKET INSIGHTS
Clinical nutrition is a pharmaceutical product that keeps a patient healthy. It enhances the metabolic system through sufficient provision of supplements like vitamins and minerals. It also treats diseases that impact the intestinal absorption, metabolism of constituents of diet, and prevent diet-related diseases. There is a rise in the need for clinical nutrition due to growing chronic and lifestyle-diseases like diabetes mellitus and inflammatory bowel disease. The total burden of cancer across the world is evaluated to have risen to 18.1 million new cases. Many more diseases like cachexia, anorexia, food allergy, etc. require clinical nutrition. The patients often have nutritional deficiency problems. In the US, every year, almost 150,000 infants and hospitalized patients get nutrition support. Therefore, the increasing number of nutrition-related diseases across the globe is projected to drive the demand for clinical nutrition.
However, the lack of awareness regarding clinical nutrition and its availability in both, developing and developed countries, is hindering the growth of the market.

REGIONAL INSIGHTS
The global clinical nutrition market is geographically segmented into Asia Pacific, North America, Europe, and the rest of the world, for further evaluation. North America procured the largest revenue share in 2019, given the relentless R&D toward the development of innovative clinical nutrition, along with the increasing aging population and chronic diseases.

COMPETITIVE INSIGHTS
With a significant number of vendors, the market is assessed to be highly competitive. Some of the established companies in the market include, American Regent Inc, B. Braun, Baxter International Inc, BASF SE, Abbott Laboratories, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
3.2.2. RISE IN ELDERLY POPULATION
3.2.3. HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
3.2.4. SURGING DEMAND IN DEVELOPING ECONOMIES
3.3. KEY RESTRAINTS
3.3.1. LACK OF AWARENESS FOR CLINICAL NUTRITION
3.3.2. COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
3.3.3. STRINGENT REGULATIONS
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. KEY INVESTMENT INSIGHTS
5. MARKET BY ROUTE OF ADMINISTRATION
5.1. ORAL
5.2. ENTERAL
5.3. PARENTERAL
6. MARKET BY APPLICATION
6.1. CANCER
6.2. NEUROLOGICAL DISEASES
6.3. GASTROINTESTINAL DISORDERS
6.4. METABOLIC DISORDERS
6.5. OTHER APPLICATIONS
7. MARKET BY END-USER
7.1. PEDIATRIC
7.2. GERIATRIC
7.3. ADULTS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. THE UNITED STATES
8.1.2. CANADA
8.2. EUROPE
8.2.1. GERMANY
8.2.2. FRANCE
8.2.3. THE UNITED KINGDOM
8.2.4. ITALY
8.2.5. RUSSIA
8.2.6. BELGIUM
8.2.7. POLAND
8.2.8. REST OF EUROPE
8.3. ASIA PACIFIC
8.3.1. JAPAN
8.3.2. CHINA
8.3.3. INDIA
8.3.4. AUSTRALIA & NEW ZEALAND
8.3.5. SOUTH KOREA
8.3.6. THAILAND
8.3.7. INDONESIA
8.3.8. VIETNAM
8.3.9. REST OF ASIA PACIFIC
8.4. REST OF WORLD
8.4.1. LATIN AMERICA
8.4.2. MIDDLE EAST & AFRICA
9. COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.2. AMERICAN REGENT INC
9.3. BASF SE
9.4. BAXTER INTERNATIONAL INC
9.5. B. BRAUN
9.6. DANONE
9.7. EXELA PHARMA SCIENCES
9.8. GRIFOLS SA
9.9. LONZA LTD
9.10. MEIJI HOLDINGS CO LTD
9.11. NESTLE HEALTH SCIENCE
9.12. OTSUKA HOLDINGS CO LTD
9.13. RECKITT BENCKISER GROUP PLC
9.14. SANOFI
9.15. SICHUAN KELUN PHARMACEUTICAL CO LTD

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - CLINICAL NUTRITION
TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION, 2019 AND 2050
TABLE 3: GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 4: GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 5: GLOBAL ORAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 6: GLOBAL ORAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 7: GLOBAL ENTERAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 8: GLOBAL ENTERAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 9: GLOBAL PARENTERAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 10: GLOBAL PARENTERAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 11: GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 13: GLOBAL CANCER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: GLOBAL CANCER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 15: GLOBAL NEUROLOGICAL DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 16: GLOBAL NEUROLOGICAL DISEASES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 17: GLOBAL GASTROINTESTINAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: GLOBAL GASTROINTESTINAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 19: GLOBAL METABOLIC DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: GLOBAL METABOLIC DISORDERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 21: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 22: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 23: GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 24: GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 25: GLOBAL PEDIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 26: GLOBAL PEDIATRIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 27: GLOBAL GERIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 28: GLOBAL GERIATRIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 29: GLOBAL ADULTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 30: GLOBAL ADULTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 31: GLOBAL CLINICAL NUTRITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 32: GLOBAL CLINICAL NUTRITION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 33: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 34: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 35: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 36: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 37: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 38: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 39: REST OF WORLD CLINICAL NUTRITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 40: REST OF WORLD CLINICAL NUTRITION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の臨床栄養市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆